Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer

• Published in: International journal of molecular sciences Vol. 23; no. 11; p. 6271
• Main Authors: Ruscitto, Federica, Roda, Niccolò, Priami, Chiara, Migliaccio, Enrica, Pelicci, Pier Giuseppe
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 03.06.2022; MDPI
• Subjects: adaptive responses; Bones; Breast cancer; Chemotherapy; Endoplasmic reticulum; Epidemiology; Ethnicity; Extravasation; Genomes; Growth factors; Heterogeneity; Hormone replacement therapy; Hypoxia; intra-tumor heterogeneity; Invasiveness; Liver; Lymphatic system; Medical prognosis; Metastases; Metastasis; metastatic cascade; Mortality; mutational profile; Nutrients; Prognosis; Review; Tumors; Whole genome sequencing; Womens health; adaptive responses; breast cancer; metastatic cascade; intra-tumor heterogeneity; mutational profile
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23116271

Metastatic disease represents the primary cause of breast cancer (BC) mortality, yet it is still one of the most enigmatic processes in the biology of this tumor. Metastatic progression includes distinct phases: invasion, intravasation, hematogenous dissemination, extravasation and seeding at distant sites, micro-metastasis formation and metastatic outgrowth. Whole-genome sequencing analyses of primary BC and metastases revealed that BC metastatization is a non-genetically selected trait, rather the result of transcriptional and metabolic adaptation to the unfavorable microenvironmental conditions which cancer cells are exposed to (e.g., hypoxia, low nutrients, endoplasmic reticulum stress and chemotherapy administration). In this regard, the latest multi-omics analyses unveiled intra-tumor phenotypic heterogeneity, which determines the polyclonal nature of breast tumors and constitutes a challenge for clinicians, correlating with patient poor prognosis. The present work reviews BC classification and epidemiology, focusing on the impact of metastatic disease on patient prognosis and survival, while describing general principles and current in vitro/in vivo models of the BC metastatic cascade. The authors address here both genetic and phenotypic intrinsic heterogeneity of breast tumors, reporting the latest studies that support the role of the latter in metastatic spreading. Finally, the review illustrates the mechanisms underlying adaptive stress responses during BC metastatic progression.